WO2010128039A1 - Biodegradable composite comprising a biodegradable polymer and a glass fiber - Google Patents

Biodegradable composite comprising a biodegradable polymer and a glass fiber Download PDF

Info

Publication number
WO2010128039A1
WO2010128039A1 PCT/EP2010/056026 EP2010056026W WO2010128039A1 WO 2010128039 A1 WO2010128039 A1 WO 2010128039A1 EP 2010056026 W EP2010056026 W EP 2010056026W WO 2010128039 A1 WO2010128039 A1 WO 2010128039A1
Authority
WO
WIPO (PCT)
Prior art keywords
biodegradable
glass fibers
mold
biodegradable polymer
composite
Prior art date
Application number
PCT/EP2010/056026
Other languages
French (fr)
Inventor
Kirsten Henken
Roelof Marissen
Detlef Olaf Alexander Schumann
Original Assignee
Dsm Ip Assets B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets B.V. filed Critical Dsm Ip Assets B.V.
Publication of WO2010128039A1 publication Critical patent/WO2010128039A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L17/00Materials for surgical sutures or for ligaturing blood vessels ; Materials for prostheses or catheters
    • A61L17/06At least partially resorbable materials
    • A61L17/10At least partially resorbable materials containing macromolecular materials
    • A61L17/12Homopolymers or copolymers of glycolic acid or lactic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L27/446Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with other specific inorganic fillers other than those covered by A61L27/443 or A61L27/46
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58Materials at least partially resorbable by the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/12Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L31/125Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L31/128Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix containing other specific inorganic fillers not covered by A61L31/126 or A61L31/127
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/148Materials at least partially resorbable by the body
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C70/00Shaping composites, i.e. plastics material comprising reinforcements, fillers or preformed parts, e.g. inserts
    • B29C70/02Shaping composites, i.e. plastics material comprising reinforcements, fillers or preformed parts, e.g. inserts comprising combinations of reinforcements, e.g. non-specified reinforcements, fibrous reinforcing inserts and fillers, e.g. particulate fillers, incorporated in matrix material, forming one or more layers and with or without non-reinforced or non-filled layers
    • B29C70/021Combinations of fibrous reinforcement and non-fibrous material
    • B29C70/025Combinations of fibrous reinforcement and non-fibrous material with particular filler
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29KINDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2995/00Properties of moulding materials, reinforcements, fillers, preformed parts or moulds
    • B29K2995/0037Other properties
    • B29K2995/0059Degradable
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29KINDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2995/00Properties of moulding materials, reinforcements, fillers, preformed parts or moulds
    • B29K2995/0037Other properties
    • B29K2995/0059Degradable
    • B29K2995/006Bio-degradable, e.g. bioabsorbable, bioresorbable or bioerodible
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29LINDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES
    • B29L2031/00Other particular articles
    • B29L2031/753Medical equipment; Accessories therefor

Definitions

  • the invention is directed to a biodegradable composite comprising a biodegradable polymer and 20-70 vol% glass fibers, a process for the preparation of a biodegradable composite and a medical implant comprising a biodegradable composite.
  • stainless steel or titanium alloys are used in orthopedic applications that require high strength. Although these materials are inert, they are also used in situations in which the need for the implant is only temporary, like in fracture fixation. Often the implant has to be retrieved during a second surgery after healing because of inflammation of the host tissue. Besides that, stress shielding can occur due to the high stiffness of the metals, so that bone loses its original strength. Other disadvantages are that the metal implants are palpable and a cold sensation can occur. In addition to the conventional metal devices, several polymer devices for temporary orthopedic applications were developed, that can be broken down by the human body. No second surgery to retrieve the implant is needed, but the strength of these devices is still insufficient.
  • a biodegradable composite material can be prepared from a biodegradable polymer and 20-70 vol% glassfibers, wherein the biodegradable composite has a flexural strength between 100 and 600 MPa.
  • the biodegradable composite has a flexural strength between 150 and 500 MPa; more preferably between 250 and 500 MPa.
  • the biodegradable composite also has a flexural modulus between 10 and 40 GPa, preferably between 15 and 35 GPa; more preferably between 20 and 35 GPa.
  • glass fibers 20-70 vol% of glass fibers is used.
  • 30-60 vol%, more preferably 40-55 vol% glass fibers is used in the composite.
  • the glass fibers that can be used are long (with an average length of more than 1.5 mm) or continuous fibers.
  • the glass fibers can be used in the biodegradable composite in a number of forms, such as strands, bundles, filaments, yarn, mats, woven fabrics and unwoven fabrics or roving.
  • a continuous fiber can also be formed into a structure by using filament winding.
  • Composites containing continuous fibers have a higher flexural strength than composites comprising long glass fibers.
  • Composites containing continuous fibers are therefore preferred.
  • the glass fibers can contain various sizings and finishes.
  • a sizing is a surface treatment or coating applied to the glass fibers during the forming operation.
  • a finishing is a surface treatment applied to the glass fibers after heat cleaning. This treatment usually consists of a water- or solvent-diluted coupling agent, which are designed to provide good interfacial adhesion of glass to the polymer.
  • the biodegradable composite comprises glass fibers having a SiO 2 content of 15-60 wt%; preferably 20-50 wt%; more preferably 20-40 wt%. Most preferably, the glass fibers are resorbable glass fibers.
  • Resorbable means that the glass fibers are resorbed in the human or animal body mainly under the influence of water and/or enzymes.
  • Resorbable glass fibers not always contain SiO 2 , but these glass fibers preferably contain more than 0.5 wt% of P 2 O 5 .
  • Specific examples of glass fibers that can be used are resorbable glass fibers of Vivoxid and Giltech.
  • the biodegradable composite also comprises a biodegradable polymer.
  • a biodegradable polymer is a polymer that can decompose in the human or animal body during a certain period of time. Decomposition of the biodegradable polymer occurs mainly under the influence of water and/or enzymes.
  • biodegradable polymers examples include poly( ⁇ -esters), which include poly(lactic acid), poly(glycolic acid), poly(p-dioxanone) and poly(3- hydroxybutyrate); tyrosine-derived polymers, which include polycarbonates, polyarylates and copolymers of these with polyethyleneglycol (PEG); natural polymers, which include starch, chitosan, collagen, cellulose, including methyl cellulose and chitin; poly( ⁇ -caprolactone), poly(propylene fumarate) and poly(trimethylene carbonate). It is also possible to use (block)copolymers made from the various monomers used to prepare the biodegradable polymers mentioned above.
  • poly( ⁇ -esters) more preferably poly(lactic acid), are preferred because the mechanical properties, i.e. the stiffness and strength, of these polymers are sufficient for use in a composite material.
  • the invention is also directed to a process for the preparation of a biodegradable composite, wherein a. the glass fibers are pre-treated with a solution of the biodegradable polymer in a solvent; b. the solvent is evaporated; c. the pre-treated glass fibers, optionally together with additional biodegradable polymer, is placed in a mold, where after the biodegradable polymer present on the fibers and/or added to the mold is melted by applying heat and pressure; d. the mold is cooled and the biodegradable composite is removed from the mold.
  • the solution of the biodegradable polymer can be easily made by the person skilled in the art.
  • the solution can be made by dissolving granules of the biodegradable polymer in a suitable solvent.
  • a dispersion of very small (i.e. sub- micron) polymer particles in a liquid can act as a solution, and thus can be used as well.
  • suitable solvents are water, alcohols, acetone, ethyl acetate, butanone, dimethyl sulfoxide, 1 , 4-dioxane, tetrahydrofurane and chloroform.
  • concentration of the biodegradable polymer in the solvent can be chosen within wide ranges and depends, for instance, on the amount of biodegradable polymer that one wants to apply on the fiber-containing glass fiber.
  • Evaporation of the solvent can be performed faster by the application of heat or an air stream.
  • the pre-treated glass fiber is placed in a mold, where after the biodegradable polymer present on the filer is melted by applying heat and pressure. In this way a composite is made and a good contact between the glass fiber and the biodegradable polymer is obtained. It is possible to apply all biodegradable polymer onto the glass fiber by repeating the application of the solution of the biodegradable polymer on the glass fiber and evaporating the solvent several times. In this way one is able to apply more biodegradable polymer onto the glass fiber, but applying the solution and drying is time consuming. Thus, normally application of just one layer is performed to obtain a good contact between the glass fiber and the biodegradable polymer.
  • the rest of the biodegradable polymer in the composite is applied to the mold together with the pre-treated glass fiber.
  • the biodegradable polymer can be mixed with the pre-treated glass fiber, or applied to the mold before, after or between the pre-treated glass fibers. After filling the mold is closed and the biodegradable polymer is melted in the mold by applying heat and pressure.
  • the best adhesion between the glass fiber and the biodegradable polymer is obtained when the biodegradable polymer used for the pretreatment of the glass fiber is the same as the biodegradable polymer added to the mold.
  • the composite according to the invention may further contain one or more additives such as stabilizers, anti-oxidants, colorants, fillers, binders, fibers, meshes, substances providing radio-opacity, surface active or surface modifying agents, foaming agents, processing aids, plasticizers, biostatic/biocidal agents, substances that provide or trigger bioactivity and any other known agents.
  • additives such as stabilizers, anti-oxidants, colorants, fillers, binders, fibers, meshes, substances providing radio-opacity, surface active or surface modifying agents, foaming agents, processing aids, plasticizers, biostatic/biocidal agents, substances that provide or trigger bioactivity and any other known agents.
  • Suitable examples of other fillers which can be used in the composite in a small amount (for instance not more than 1 wt%), are e.g. bone-mineral based fillers, and binders which are described in U.S. Patent Number 6,808,585B2 in columns 8-10 and in U.S. Patent Number 7,044,972B2 in column 4, I. 30-43, which are herein incorporated by reference.
  • Typical fillers are selected from the group of calcium-based fillers (such as calcium phosphate, hydroxyapatite, tricalcium phosphate, calcium sulfate, demineralized bone, autologous bone, coralline substances).
  • the invention is also directed to a medical implant comprising the biodegradable composite.
  • medical implants are a screw, a pin, a plate, a suture, a mesh, a net, a film, a tube, a balloon, a bag, a rod, an anchor, a valve, a ring, a stent, a cage, a spacer, a graft, a porous or open structure, a scaffold and/or components thereof.
  • the invention will hereafter be described in more detail by the following examples that by no means limit the scope of the invention.
  • Methyl cellulose (MC) Methyl from Perfax
  • Chloroform solvent obtained from Sigma-Aldrich
  • Glass fibers 1.
  • Glass fiber textile Satin weave SS0303 from Ten Cate Advanced Composites
  • flexural modulus and flexural strength of the composites were determined according to ASTM test D790 on a Zwick/Roell 20 kN test bench. Test samples were prepared with a Unitom cutting machine while cooled with water to avoid defects on the edges that can cause premature failure. The flexural modulus was measured as the tangent at a loading of 20 N. The maximal flexural strength ( ⁇ flex) is based on the maximal loading (Fmax):
  • Lspan is the span length
  • w is the width of the specimen
  • t is the thickness of the specimen
  • tmean is the average thickness of specimens of one composite.
  • optical microscopy optical microscopy
  • SEM scanning electron microscopy
  • C-scanning ultrasonic transmission scanning
  • test specimens were sometimes embedded and polished to optimize the quality of the resulting images.
  • Optical microscopy was performed on a Leica DC 300F microscope with which magnifications varying from 2.5 to 100 could be obtained.
  • visual light and a system of lenses are used to image small samples.
  • depth imaging of samples is not possible with this technique and limited magnification is feasible.
  • Optical microscopy was used to get an indication of the quality of the composites.
  • Scanning electron microscopy was executed on a JEOL-JSM7500F.
  • SEM images sample surfaces by scanning with a high-energy beam of electrons and measuring the electrons that are scattered by the surface as well as the electrons produced by it.
  • SEM is able to image samples in depth and to magnify from 25 up to 10 6 times. With this imaging technique, the quality of the composite, including wetting of fibers, voids, microcracks, and adhesion was investigated, as well as the failure mechanism occurring in the flexural test.
  • Ultrasonic transmission scanning was performed on a Midas system. With this technique, the acoustic impedance of a material is measured by transmitting ultrasonic energy to the sample and measuring the reflected energy. In a program (ALIS), the intensity of the reflected energy is converted from decibels to a tone of grey, in which darker grey represents a higher intensity.
  • ALIS a program
  • the acoustic impedance is increased by voids, cracks, porosity, fiber- matrix interfaces, fiber distribution, fiber volume fraction, foreign inclusions, and so on. Consequently, dark grey indicated that more irregularities were present in that area. Intact parts of the composite plates were scanned in order to make a rough estimation of the quality of the composite.
  • the steps that were carried out in the preparation of a composite of PLA sheets and glass fiber textile are listed below. 1.
  • the PLA granules were dried in an oven at 80 0 C during five hours.
  • PLA granules PLA granules.
  • the mass of the PLA and the number of glass fiber textiles was calculated based on the required dimensions and fiber volume fraction. The goal was to make a plate of 300x150x2.5 mm with a fiber volume fraction of 0.5. To obtain this, nine sheets of glass fiber textile were needed, combined with 80 g of PLA.
  • the PLA granules were ground three times in a concentric grinder under nitrogen to granules with a diameter of approximately 1-2 mm. 3. Eight sheets (30x15 cm) of glass fiber textile were made.
  • the system was consolidated in a Fontijne press (TP 1000). The consolidation steps are shown below.
  • the steps that were carried out in the preparation of a composite of pre-wetted glass fiber textiles are listed below. 1. The mass of PLA and the number of glass fiber textiles was calculated based on the required dimensions. The goal was to make a plate of 300x150x2.5 mm. Therefore, eleven sheets of glass fiber textiles were combined with 73 g PLA. 2. Eleven sheets (30x15 cm) of glass fiber textile were made.
  • the textiles were cut into rectangular impregnated textiles of 14x29 cm. 6.
  • the eleven sheets were stacked on top of each other in the mold and the mold was closed.
  • the composite was consolidated in a Fontijne press. The steps of the consolidation process are shown below. During the process, the temperatures in the mold were monitored.
  • Example Il The steps that were carried out in the preparation of a composite of pre-wetted glass fiber textiles and PLA powder are listed below.
  • the mass of the PLA and the number of glass fiber textiles was calculated based on the required dimensions and fiber volume fraction. The goal was to make a plate with the same dimensions and fiber volume fraction as the plate obtained from glass fiber textiles combined with PLA powder. Therefore, eight sheets of glass fiber textile were needed and 80 g of PLA was added to this.
  • the PLA granules were ground three times in a concentric grinder under nitrogen to granules with a diameter of approximately 1 mm.
  • the steps that were carried out to make a composite of filament wound continuous glass fiber and PLA is listed below.
  • the fiber volume fraction, the mass of PLA, the shift between fibers, and the number of layers were defined, considering the trade-off between shift, fiber volume fraction, and thickness of the final composite.
  • the goal was to produce two plates of 150x150x1.4 mm with a fiber volume fraction of 0.4. Therefore, a total of 23 layers was needed with a distance of 1.5 mm between the fibers and 2 times 33.9 g PLA.
  • Three layers of glass fiber with a tex-value of 136 g/km were filament wound around a winding mold with a shift of 1.5 mm.
  • the goal of the examples was to prepare a biodegradable composite with a flexural stiffness, as shown by the flexural modulus, and flexural strength comparable to that of bone.
  • the flexural stiffness of bone is 20-40 GPa; the flexural strength of bone is about 200 MPa.
  • the flexural strength of the composite should preferably be higher than the flexural strength of bone to limit the risk of failure of the implant. It is clear from the examples that a biodegradable composite, wherein the glass fiber was pre-treated with a solution of PLA, has a much higher flexural strength when compared to a composite prepared from a glass fiber which is not pre- treated.

Abstract

The invention is directed to biodegradable composite comprising a biodegradable polymer and 20-70 vol% glass fibers, wherein the biodegradable composite has a flexural strength between 100 and 600 MPa and to a process for the preparation of a biodegradable composite comprising a biodegradable polymer and a glass fiber, wherein a. the glass fibers are pre-treated with a solution of the biodegradable polymer in a solvent; b. the solvent is evaporated; c. the pre-treated glass fibers, optionally together with additional biodegradable polymer, is placed in a mold, where after the biodegradable polymer present on the glass fibers and/or added to the mold is melted by applying heat and pressure; d. the mold is cooled and the biodegradable composite is removed from the mold.

Description

BIODEGRADABLE COMPOSITE COMPRISING A BIODEGRADABLE POLYMER AND A GLASS FIBER
The invention is directed to a biodegradable composite comprising a biodegradable polymer and 20-70 vol% glass fibers, a process for the preparation of a biodegradable composite and a medical implant comprising a biodegradable composite.
In orthopedic applications that require high strength, usually stainless steel or titanium alloys are used. Although these materials are inert, they are also used in situations in which the need for the implant is only temporary, like in fracture fixation. Often the implant has to be retrieved during a second surgery after healing because of inflammation of the host tissue. Besides that, stress shielding can occur due to the high stiffness of the metals, so that bone loses its original strength. Other disadvantages are that the metal implants are palpable and a cold sensation can occur. In addition to the conventional metal devices, several polymer devices for temporary orthopedic applications were developed, that can be broken down by the human body. No second surgery to retrieve the implant is needed, but the strength of these devices is still insufficient.
This drawback can potentially be overcome by using composite technology. In composite materials, usually a relatively flexible matrix is combined with a stiff and strong reinforcement material to enhance the mechanical properties of the matrix. For these temporary high-strength applications, biodegradable glass or mineral material can be used to improve the stiffness and strength of a biodegradable polymer matrix. In the prior art several attempts to produce such a composite were reported. According to the prior art bioactive glass particles, hydroxyapatite powder, or short glass fibers were used to enhance the properties of a biodegradable polymer. However, the fracture strength of these composites is still low.
At the moment no appropriate biodegradable material is available for fraction fixation or other load-bearing orthopedic applications, because of the high strength that is required for this composite material.
There thus is a need for a composite material which is biodegradable and that can be used in medical applications that require high strength and a stiffness compared to the stiffness of bone. These medical applications include fracture fixation, tendon reattachment, spinal fixation, and spinal cages. It has now surprisingly been discovered that a biodegradable composite material can be prepared from a biodegradable polymer and 20-70 vol% glassfibers, wherein the biodegradable composite has a flexural strength between 100 and 600 MPa. Preferably, the biodegradable composite has a flexural strength between 150 and 500 MPa; more preferably between 250 and 500 MPa.
Preferably, the biodegradable composite also has a flexural modulus between 10 and 40 GPa, preferably between 15 and 35 GPa; more preferably between 20 and 35 GPa.
In the biodegradable composite material according to the invention 20-70 vol% of glass fibers is used. Preferably, 30-60 vol%, more preferably 40-55 vol% glass fibers is used in the composite. The glass fibers that can be used are long (with an average length of more than 1.5 mm) or continuous fibers.
The glass fibers can be used in the biodegradable composite in a number of forms, such as strands, bundles, filaments, yarn, mats, woven fabrics and unwoven fabrics or roving. A continuous fiber can also be formed into a structure by using filament winding. Composites containing continuous fibers have a higher flexural strength than composites comprising long glass fibers. Composites containing continuous fibers are therefore preferred. The glass fibers can contain various sizings and finishes. A sizing is a surface treatment or coating applied to the glass fibers during the forming operation. A finishing is a surface treatment applied to the glass fibers after heat cleaning. This treatment usually consists of a water- or solvent-diluted coupling agent, which are designed to provide good interfacial adhesion of glass to the polymer.
Preferably, the biodegradable composite comprises glass fibers having a SiO2 content of 15-60 wt%; preferably 20-50 wt%; more preferably 20-40 wt%. Most preferably, the glass fibers are resorbable glass fibers.
Resorbable means that the glass fibers are resorbed in the human or animal body mainly under the influence of water and/or enzymes. Resorbable glass fibers not always contain SiO2, but these glass fibers preferably contain more than 0.5 wt% of P2O5. Specific examples of glass fibers that can be used are resorbable glass fibers of Vivoxid and Giltech.
The biodegradable composite also comprises a biodegradable polymer. A biodegradable polymer is a polymer that can decompose in the human or animal body during a certain period of time. Decomposition of the biodegradable polymer occurs mainly under the influence of water and/or enzymes. Examples of biodegradable polymers are poly(α-esters), which include poly(lactic acid), poly(glycolic acid), poly(p-dioxanone) and poly(3- hydroxybutyrate); tyrosine-derived polymers, which include polycarbonates, polyarylates and copolymers of these with polyethyleneglycol (PEG); natural polymers, which include starch, chitosan, collagen, cellulose, including methyl cellulose and chitin; poly(ε-caprolactone), poly(propylene fumarate) and poly(trimethylene carbonate). It is also possible to use (block)copolymers made from the various monomers used to prepare the biodegradable polymers mentioned above.
Mixtures of the above-mentioned biodegradable polymers can also be used.
The poly(α-esters), more preferably poly(lactic acid), are preferred because the mechanical properties, i.e. the stiffness and strength, of these polymers are sufficient for use in a composite material.
The invention is also directed to a process for the preparation of a biodegradable composite, wherein a. the glass fibers are pre-treated with a solution of the biodegradable polymer in a solvent; b. the solvent is evaporated; c. the pre-treated glass fibers, optionally together with additional biodegradable polymer, is placed in a mold, where after the biodegradable polymer present on the fibers and/or added to the mold is melted by applying heat and pressure; d. the mold is cooled and the biodegradable composite is removed from the mold.
The solution of the biodegradable polymer can be easily made by the person skilled in the art. For instance, the solution can be made by dissolving granules of the biodegradable polymer in a suitable solvent. A dispersion of very small (i.e. sub- micron) polymer particles in a liquid can act as a solution, and thus can be used as well.
Examples of suitable solvents are water, alcohols, acetone, ethyl acetate, butanone, dimethyl sulfoxide, 1 , 4-dioxane, tetrahydrofurane and chloroform. The concentration of the biodegradable polymer in the solvent can be chosen within wide ranges and depends, for instance, on the amount of biodegradable polymer that one wants to apply on the fiber-containing glass fiber.
Evaporation of the solvent can be performed faster by the application of heat or an air stream. - A -
The pre-treated glass fiber is placed in a mold, where after the biodegradable polymer present on the filer is melted by applying heat and pressure. In this way a composite is made and a good contact between the glass fiber and the biodegradable polymer is obtained. It is possible to apply all biodegradable polymer onto the glass fiber by repeating the application of the solution of the biodegradable polymer on the glass fiber and evaporating the solvent several times. In this way one is able to apply more biodegradable polymer onto the glass fiber, but applying the solution and drying is time consuming. Thus, normally application of just one layer is performed to obtain a good contact between the glass fiber and the biodegradable polymer.
The rest of the biodegradable polymer in the composite is applied to the mold together with the pre-treated glass fiber. The biodegradable polymer can be mixed with the pre-treated glass fiber, or applied to the mold before, after or between the pre-treated glass fibers. After filling the mold is closed and the biodegradable polymer is melted in the mold by applying heat and pressure.
The best adhesion between the glass fiber and the biodegradable polymer is obtained when the biodegradable polymer used for the pretreatment of the glass fiber is the same as the biodegradable polymer added to the mold. The better the adhesion between the glass fiber and the biodegradable polymer is, the better are the stiffness and the strength of the composite.
The composite according to the invention may further contain one or more additives such as stabilizers, anti-oxidants, colorants, fillers, binders, fibers, meshes, substances providing radio-opacity, surface active or surface modifying agents, foaming agents, processing aids, plasticizers, biostatic/biocidal agents, substances that provide or trigger bioactivity and any other known agents.
Suitable examples of other fillers, which can be used in the composite in a small amount (for instance not more than 1 wt%), are e.g. bone-mineral based fillers, and binders which are described in U.S. Patent Number 6,808,585B2 in columns 8-10 and in U.S. Patent Number 7,044,972B2 in column 4, I. 30-43, which are herein incorporated by reference. Typical fillers are selected from the group of calcium-based fillers (such as calcium phosphate, hydroxyapatite, tricalcium phosphate, calcium sulfate, demineralized bone, autologous bone, coralline substances).
The invention is also directed to a medical implant comprising the biodegradable composite. Examples of medical implants are a screw, a pin, a plate, a suture, a mesh, a net, a film, a tube, a balloon, a bag, a rod, an anchor, a valve, a ring, a stent, a cage, a spacer, a graft, a porous or open structure, a scaffold and/or components thereof. The invention will hereafter be described in more detail by the following examples that by no means limit the scope of the invention.
EXAMPLES
Materials
Biodegradable polymers:
Poly(lactic acid) (PLA): 4032D from Natureworks LLC
Methyl cellulose (MC): Methyl from Perfax
Solvent
Chloroform: solvent obtained from Sigma-Aldrich
Glass fibers 1. Glass fiber textile: Satin weave SS0303 from Ten Cate Advanced Composites
Chemical composition: 52-56 wt% SiO2, 16-25 wt% CaO, 12-16 wt% AI2O3, 5-10 wt% B2O3, 0-2 wt% NaO and K2O, 0-5 wt% MgO, 0.05-0.4 wt% Fe2O3, 0-0.8 wt% TiO2, 0-1.0 wt% fluorides 2. Continuous glass fiber: EC9 136 from PPG Chemical composition: 52-56 wt% SiO2, 16-25 wt% CaO, 12-16 wt% AI2O3,
5-10 wt% B2O3, 0-2 wt% NaO and K2O, 0-5 wt% MgO, 0.05-0.4 wt% Fe2O3, 0-0.8 wt% TiO2, 0-1.0 wt% fluorides
Flexural test The flexural modulus and flexural strength of the composites were determined according to ASTM test D790 on a Zwick/Roell 20 kN test bench. Test samples were prepared with a Unitom cutting machine while cooled with water to avoid defects on the edges that can cause premature failure. The flexural modulus was measured as the tangent at a loading of 20 N. The maximal flexural strength (σflex) is based on the maximal loading (Fmax):
σflex = 3FmaxLspan 2wt2 with:
L = 40 tmean
in which Lspan is the span length, w is the width of the specimen, t is the thickness of the specimen, and tmean is the average thickness of specimens of one composite.
Imaging
Three imaging techniques were utilized to gain insight in the quality of the composite: optical microscopy, scanning electron microscopy (SEM), and ultrasonic transmission scanning (C-scanning). Cross sections and interlaminar sections of test specimens were investigated with optical microscopy and SEM, while complete plates were investigated with C-scanning.
The sections of test specimens were sometimes embedded and polished to optimize the quality of the resulting images.
Optical microscopy was performed on a Leica DC 300F microscope with which magnifications varying from 2.5 to 100 could be obtained. In an optical microscope, visual light and a system of lenses are used to image small samples. In depth imaging of samples is not possible with this technique and limited magnification is feasible. Optical microscopy was used to get an indication of the quality of the composites.
Scanning electron microscopy was executed on a JEOL-JSM7500F. SEM images sample surfaces by scanning with a high-energy beam of electrons and measuring the electrons that are scattered by the surface as well as the electrons produced by it. SEM is able to image samples in depth and to magnify from 25 up to 106 times. With this imaging technique, the quality of the composite, including wetting of fibers, voids, microcracks, and adhesion was investigated, as well as the failure mechanism occurring in the flexural test.
Ultrasonic transmission scanning was performed on a Midas system. With this technique, the acoustic impedance of a material is measured by transmitting ultrasonic energy to the sample and measuring the reflected energy. In a program (ALIS), the intensity of the reflected energy is converted from decibels to a tone of grey, in which darker grey represents a higher intensity.
The acoustic impedance is increased by voids, cracks, porosity, fiber- matrix interfaces, fiber distribution, fiber volume fraction, foreign inclusions, and so on. Consequently, dark grey indicated that more irregularities were present in that area. Intact parts of the composite plates were scanned in order to make a rough estimation of the quality of the composite.
Sample preparation
Comparative experiment A
The steps that were carried out in the preparation of a composite of PLA sheets and glass fiber textile are listed below. 1. The PLA granules were dried in an oven at 80 0C during five hours.
2. 30 g PLA granules were compressed to sheets according to the protocol given below. This was repeated nine times to obtain nine sheets. The resulting sheets had a thickness of 1-2 mm.
3. Eight sheets (30x30 cm) of glass fiber textile were made. 4. The eight glass fiber textiles and nine PLA sheets were subsequently stacked, and consolidated in a Joos press (LAP100) by heating up the stack while compression was applied. The protocol used in this process was a standard consolidation protocol of the Joos press.
Pressing protocol of PLA sheets
Heat up press to 200 0C.
Stack stainless steel plates, Teflon sheets (to separate the PLA from the press), and
PLA granules.
Heat up PLA without applying pressure during 10 minutes Apply 10 kN during 5 minutes
Apply 20 kN during 5 minutes
Apply 30 kN during 5 minutes
Apply 40 kN during 5 minutes
Apply 50 kN during 5 minutes Apply 60 kN during 5 minutes Remove Teflon sheets with PLA sheet in between from the press Cool the PLA sheet in ambient air during approximately 5 minutes Separate PLA sheet from Teflon sheets
Comparative experiment B
The steps that were carried out in the preparation of a composite of glass fiber textile and PLA powder are listed below.
1. The mass of the PLA and the number of glass fiber textiles was calculated based on the required dimensions and fiber volume fraction. The goal was to make a plate of 300x150x2.5 mm with a fiber volume fraction of 0.5. To obtain this, nine sheets of glass fiber textile were needed, combined with 80 g of PLA.
2. The PLA granules were ground three times in a concentric grinder under nitrogen to granules with a diameter of approximately 1-2 mm. 3. Eight sheets (30x15 cm) of glass fiber textile were made.
4. 8 g of PLA powder was distributed manually over the bottom of the mold. After this a glass fiber textile sheet was added on top of this layer. Then the next 8 g of PLA was distributed on top of the glass fiber textile. This was repeated until nine layers of PLA and eight layers of glass fiber textile were stacked subsequently. Finally, the mold was closed.
The system was consolidated in a Fontijne press (TP 1000). The consolidation steps are shown below.
Consolidation protocol of the composite of glass fiber textiles and PLA powder. Heat up press to 200 0C.
Place the mold in the press and use Teflon sheets to separate the mold from the press
Apply a force of 5 kN during 13 minutes
Apply a force of 8 kN during 9 minutes
Cool down the press to 41 0C, while the applied force is maintained at 8 kN Take the mold out of the press and open it
Example I
The steps that were carried out in the preparation of a composite of pre-wetted glass fiber textiles are listed below. 1. The mass of PLA and the number of glass fiber textiles was calculated based on the required dimensions. The goal was to make a plate of 300x150x2.5 mm. Therefore, eleven sheets of glass fiber textiles were combined with 73 g PLA. 2. Eleven sheets (30x15 cm) of glass fiber textile were made.
3. A solution of PLA and chloroform was prepared by adding
80 g PLA granules in parts to 800 mL chloroform. The solution was stirred overnight.
4. Multiple layers of the solution were applied to eleven glass fiber textiles (30x15 cm). The first layer was applied by dipping the sheets in the solution, while the following layers were applied to the sheets with a brush. Before a next layer was added, the sheets were dried for at least one hour in a hood on a Teflon sheet.
5. The textiles were cut into rectangular impregnated textiles of 14x29 cm. 6. The eleven sheets were stacked on top of each other in the mold and the mold was closed. The composite was consolidated in a Fontijne press. The steps of the consolidation process are shown below. During the process, the temperatures in the mold were monitored.
Consolidation protocol of prewetted glass fiber textiles.
Heat up press to 200 0C.
Place the mold in the press and use Teflon sheets to separate the mold from the press
Apply a force of 20 kN during 15 minutes
Apply a force of 30 kN during 4 minutes Apply a force of 50 kN during two minutes
Cool down the press to 36 0C, while the applied force is maintained at 50 kN
Take the mold out of the press and open it.
Example Il The steps that were carried out in the preparation of a composite of pre-wetted glass fiber textiles and PLA powder are listed below.
1. The mass of the PLA and the number of glass fiber textiles was calculated based on the required dimensions and fiber volume fraction. The goal was to make a plate with the same dimensions and fiber volume fraction as the plate obtained from glass fiber textiles combined with PLA powder. Therefore, eight sheets of glass fiber textile were needed and 80 g of PLA was added to this.
2. Eight sheets (30x15 cm) of glass fiber textile were made.
3. The PLA granules were ground three times in a concentric grinder under nitrogen to granules with a diameter of approximately 1 mm.
4. A solution of 11 g in 1 10 mL chloroform was prepared. The solution was applied to one side of the glass fiber textiles with a brush.
5. A solution of 11 g in 1 10 mL chloroform was prepared. The solution was applied to the other side of the glass fiber textiles with a brush. 6. 6 g of PLA powder was distributed manually over the bottom of the mold. After this, a glass fiber textile sheet was added on top of this layer. This was repeated until nine layers of PLA and eight layers of glass fiber textile were stacked subsequently. Finally, the mold was closed. 7. The composite was consolidated in a Joos press, of which the protocol is shown below.
Consolidation protocol of the composite of pre-wetted glass fiber textiles and PLA powder.
Heat up press to 200 0C. Place the mold in the press and use Teflon sheets to separate the mold from the press and apply 5 kN until the temperature within the mold is 195 0C.
Apply 20 kN during 5 minutes
Apply 30 kN during 5 minutes
Cool down the press to 20 0C, while the applied force is maintained at 30 kN Take the mold out of the press and open it
Example III
The steps that were carried out to make a composite of filament wound continuous glass fiber and PLA is listed below. 1. The fiber volume fraction, the mass of PLA, the shift between fibers, and the number of layers were defined, considering the trade-off between shift, fiber volume fraction, and thickness of the final composite. The goal was to produce two plates of 150x150x1.4 mm with a fiber volume fraction of 0.4. Therefore, a total of 23 layers was needed with a distance of 1.5 mm between the fibers and 2 times 33.9 g PLA. 2. Three layers of glass fiber with a tex-value of 136 g/km were filament wound around a winding mold with a shift of 1.5 mm.
3. A solution of 11.0 g of PLA in 170 ml. chloroform was prepared.
4. A layer of this solution was applied to one side of the wound structure and dried for one hour.
5. A layer of this solution was applied to the other side of the wound structure and dried for one hour.
6. The two obtained plates were cut out.
7. The rest of the solution was applied to both sheets on both sides with a brush. 8. The following layers were produced according to the procedure described above under numbers 2-7. These fiber layers were treated with a solution of 14.2 g PLA dissolved in approximately 200 mL chloroform, which was applied to the fibers.
9. The obtained layers were placed in the mold in two stacks. The direction of one layer was different from the previous or next layer to obtain a 0°-90°-0°-:::-
0 ° ply sequence.
10. The mold was closed and the composite was consolidated according to the protocol shown below.
Consolidation protocol of the composite of filament wound glass fibers and PLA.
Heat up press to 200 0C.
Place the mold in the press and use Teflon sheets to separate the mold from the press
Close the press and apply 5 kN until the temperature in the mold is 195 0C.
Apply 20 kN during 5 minutes Apply 30 kN during 5 minutes
Cool down the press to 20 0C, while the applied force is maintained at 30 kN
Table A
Overview of the flexural properties and the quality of all prepared and tested composites.
Figure imgf000013_0001
The adhesion was categorized in four groups: 0 = no matrix in between fibers or on loose fibers; 1 = matrix present in between fibers, but not on loose fibers; 2 = matrix present in between fibers, and some matrix sticking to loose fibers; 3 = matrix present in between fibers and a lot of matrix is sticking to loose fibers.
The goal of the examples was to prepare a biodegradable composite with a flexural stiffness, as shown by the flexural modulus, and flexural strength comparable to that of bone. The flexural stiffness of bone is 20-40 GPa; the flexural strength of bone is about 200 MPa.
The flexural strength of the composite should preferably be higher than the flexural strength of bone to limit the risk of failure of the implant. It is clear from the examples that a biodegradable composite, wherein the glass fiber was pre-treated with a solution of PLA, has a much higher flexural strength when compared to a composite prepared from a glass fiber which is not pre- treated.

Claims

1. Biodegradable composite comprising a biodegradable polymer and 20-70 vol% glass fibers, wherein the biodegradable composite has a flexural strength between 100 and 600 MPa.
2. Biodegradable composite according to claim 1 , wherein the biodegradable composite has a flexural modulus between 10 and 40 GPa.
3. Biodegradable composite according to claim 1 or 2, wherein the glass fibers are continuous glass fibers.
4. Biodegradable composite according to any one of claims 1-3, wherein the glass fibers have a SiO2 content of 15-60 wt%.
5. Biodegradable composite according to any one of claims 1-4, wherein the glass fibers are resorbable glass fibers.
6. Biodegradable composite according to any one of claims 1-5, wherein the biodegradable polymer comprises a poly(α-ester) or copolymers thereof.
7. Biodegradable composite according to any one of claims 1-6, wherein the biodegradable polymer is poly(lactic acid).
8. Process for the preparation of a biodegradable composite according to anyone of claims 1-7, wherein a. the glass fibers are pre-treated with a solution of the biodegradable polymer in a solvent; b. the solvent is evaporated; c. the pre-treated glass fibers, optionally together with additional biodegradable polymer, is placed in a mold, where after the biodegradable polymer present on the fibers and/or added to the mold is melted by applying heat and pressure; d. the mold is cooled and the biodegradable composite is removed from the mold.
9. Process according to claim 8, wherein the biodegradable polymer used for the pretreatment of the glass fibers is the same as the biodegradable polymer added to the mold.
10. Medical implant comprising a biodegradable composite according to claim 1-6, wherein the medical implant is chosen from a screw, a pin, a plate, a suture, a mesh, a net, a film, a tube, a balloon, a bag, a rod, an anchor, a valve, a ring, a stent, a cage, a spacer, a graft, a porous or open structure, a scaffold and/or components thereof.
PCT/EP2010/056026 2009-05-07 2010-05-04 Biodegradable composite comprising a biodegradable polymer and a glass fiber WO2010128039A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09159655 2009-05-07
EP09159655.1 2009-05-07

Publications (1)

Publication Number Publication Date
WO2010128039A1 true WO2010128039A1 (en) 2010-11-11

Family

ID=41268255

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2010/056026 WO2010128039A1 (en) 2009-05-07 2010-05-04 Biodegradable composite comprising a biodegradable polymer and a glass fiber

Country Status (1)

Country Link
WO (1) WO2010128039A1 (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103271760A (en) * 2013-05-27 2013-09-04 中国科学院化学研究所 High-intensity multi-degradation-resistant-protection degradable internal fracture fixation materials and preparation method thereof
WO2013136089A1 (en) * 2012-03-16 2013-09-19 The University Court Of The University Of Edinburgh Polymer-glass composite material
CN106039424A (en) * 2016-05-25 2016-10-26 南京凤源新材料科技有限公司 Novel polylactic acid and glass fiber composite material used for fixing skeleton
WO2018002917A1 (en) 2016-06-27 2018-01-04 Ossio Ltd. Fiber reinforced biocomposite medical implants with high mineral content
WO2019049062A1 (en) 2017-09-07 2019-03-14 Ossio Ltd. Fiber reinforced biocomposite threaded implants
WO2019123462A1 (en) 2017-12-20 2019-06-27 Ossio Ltd. Fiber bundle reinforced biocomposite medical implants
EP3628249A1 (en) 2014-12-26 2020-04-01 Ossio Ltd Continuous-fiber reinforced biocomposite medical implants
CN112521737A (en) * 2020-12-15 2021-03-19 河南银金达新材料股份有限公司 Preparation process of high-strength polylactic acid composite material
EP3470097B1 (en) 2017-10-16 2021-03-31 Arctic Biomaterials Oy Orthopedic bioabsorbable implants

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990000410A1 (en) * 1988-07-05 1990-01-25 Biocon Oy Reinforced polymeric biomaterial films
US5522895A (en) * 1993-07-23 1996-06-04 Rice University Biodegradable bone templates
US6031148A (en) * 1990-12-06 2000-02-29 W. L. Gore & Associates, Inc. Implantable bioabsorbable article
US6197410B1 (en) * 1998-03-09 2001-03-06 Stick Tech Oy Prepreg
US6344496B1 (en) * 1997-04-11 2002-02-05 Osteobiologics, Inc. Biodegradable implant material comprising bioactive ceramic
US20050226904A1 (en) * 2002-03-15 2005-10-13 Hoon Choi Fibrous composite for tissue engineering
EP1872806A1 (en) * 2006-06-28 2008-01-02 Vivoxid Oy Implant, its uses and methods for making it
WO2008112912A2 (en) * 2007-03-13 2008-09-18 Smith & Nephew, Inc. Internal fixation devices

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990000410A1 (en) * 1988-07-05 1990-01-25 Biocon Oy Reinforced polymeric biomaterial films
US6031148A (en) * 1990-12-06 2000-02-29 W. L. Gore & Associates, Inc. Implantable bioabsorbable article
US5522895A (en) * 1993-07-23 1996-06-04 Rice University Biodegradable bone templates
US6344496B1 (en) * 1997-04-11 2002-02-05 Osteobiologics, Inc. Biodegradable implant material comprising bioactive ceramic
US6197410B1 (en) * 1998-03-09 2001-03-06 Stick Tech Oy Prepreg
US20050226904A1 (en) * 2002-03-15 2005-10-13 Hoon Choi Fibrous composite for tissue engineering
EP1872806A1 (en) * 2006-06-28 2008-01-02 Vivoxid Oy Implant, its uses and methods for making it
WO2008112912A2 (en) * 2007-03-13 2008-09-18 Smith & Nephew, Inc. Internal fixation devices

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013136089A1 (en) * 2012-03-16 2013-09-19 The University Court Of The University Of Edinburgh Polymer-glass composite material
CN103271760A (en) * 2013-05-27 2013-09-04 中国科学院化学研究所 High-intensity multi-degradation-resistant-protection degradable internal fracture fixation materials and preparation method thereof
EP3628249A1 (en) 2014-12-26 2020-04-01 Ossio Ltd Continuous-fiber reinforced biocomposite medical implants
CN106039424A (en) * 2016-05-25 2016-10-26 南京凤源新材料科技有限公司 Novel polylactic acid and glass fiber composite material used for fixing skeleton
CN106039424B (en) * 2016-05-25 2019-04-05 南京凤源新材料科技有限公司 A kind of novel polylactic acid glass fiber composite material for skeletal fixation
WO2018002917A1 (en) 2016-06-27 2018-01-04 Ossio Ltd. Fiber reinforced biocomposite medical implants with high mineral content
WO2019049062A1 (en) 2017-09-07 2019-03-14 Ossio Ltd. Fiber reinforced biocomposite threaded implants
EP3470097B1 (en) 2017-10-16 2021-03-31 Arctic Biomaterials Oy Orthopedic bioabsorbable implants
US11813007B2 (en) 2017-10-16 2023-11-14 Arctic Biomaterials Oy Orthopedic bioabsorbable implants
WO2019123462A1 (en) 2017-12-20 2019-06-27 Ossio Ltd. Fiber bundle reinforced biocomposite medical implants
CN112521737A (en) * 2020-12-15 2021-03-19 河南银金达新材料股份有限公司 Preparation process of high-strength polylactic acid composite material
CN112521737B (en) * 2020-12-15 2023-04-14 河南银金达新材料股份有限公司 Preparation process of high-strength polylactic acid composite material

Similar Documents

Publication Publication Date Title
WO2010128039A1 (en) Biodegradable composite comprising a biodegradable polymer and a glass fiber
Shuai et al. Accelerated degradation of HAP/PLLA bone scaffold by PGA blending facilitates bioactivity and osteoconductivity
Peroglio et al. Toughening of bio-ceramics scaffolds by polymer coating
Rajzer et al. Electrospun gelatin/poly (ε-caprolactone) fibrous scaffold modified with calcium phosphate for bone tissue engineering
Kim et al. A poly (lactide‐co‐glycolide)/hydroxyapatite composite scaffold with enhanced osteoconductivity
He et al. Incorporation of microfibrillated cellulose into collagen-hydroxyapatite scaffold for bone tissue engineering
Peroglio et al. Mechanical properties and cytocompatibility of poly (ε-caprolactone)-infiltrated biphasic calcium phosphate scaffolds with bimodal pore distribution
Hasan et al. The influence of coupling agents on mechanical property retention and long-term cytocompatibility of phosphate glass fibre reinforced PLA composites
Aydin et al. Hydroxyapatite nanorod-reinforced biodegradable poly (L-lactic acid) composites for bone plate applications
Colquhoun et al. Mechanical behaviour of degradable phosphate glass fibres and composites—a review
Shen et al. Preparation and mechanical properties of carbon fiber reinforced hydroxyapatite/polylactide biocomposites
WO2002065955A1 (en) Artificial pyramid
Sharmin et al. Cytocompatibility, mechanical and dissolution properties of high strength boron and iron oxide phosphate glass fibre reinforced bioresorbable composites
Kino et al. Preparation and characterization of multilayered hydroxyapatite/silk fibroin film
Atila et al. Bacterial cellulose-reinforced boron-doped hydroxyapatite/gelatin scaffolds for bone tissue engineering
Balasubramanian et al. Bi-layered porous constructs of PCL-coated 45S5 bioactive glass and electrospun collagen-PCL fibers
Pattanashetti et al. Development of novel 3D scaffolds using BioExtruder by varying the content of hydroxyapatite and silica in PCL matrix for bone tissue engineering
Mehboob et al. Effect of air plasma treatment on mechanical properties of bioactive composites for medical application: Composite preparation and characterization
Ali et al. Novel biodegradable hybrid composite of polylactic acid (PLA) matrix reinforced by bioactive glass (BG) fibres and magnesium (Mg) wires for orthopaedic application
Zhang et al. Preparation of poly (lactic acid)/sintered hydroxyapatite composite biomaterial by supercritical CO 2
Ganguly et al. Electrospun and 3D printed polymeric materials for one-stage critical-size long bone defect regeneration inspired by the Masquelet technique: Recent Advances
Zou et al. Degradation behaviors of electrospun fibrous composites of hydroxyapatite and chemically modified poly (DL-lactide)
Thomas et al. Preparation and characterization of glass–ceramic reinforced alginate scaffolds for bone tissue engineering
Backes et al. Development of poly (Ɛ-polycaprolactone)/hydroxyapatite composites for bone tissue regeneration
Andric et al. Fabrication and characterization of three-dimensional electrospun scaffolds for bone tissue engineering

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10720896

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 10720896

Country of ref document: EP

Kind code of ref document: A1